Insemigen

📍 London, United Kingdom🗓 Founded 2022👥 6 employees💰 Last funded Feb 2024
Biotechnology Research🌐 insemigen.com
Website LinkedIn
Insemigen Ltd is poised to revolutionise the way that consumers and suppliers interact with, and access, artificial reproductive technologies for animals, across the globe. The launch of Insemin8, the world’s first “semen marketplace” will prove a significant and positive step forward for animal health, which will ultimately improve genetic diversity and breeding standards around the world. Increasing the uptake of artificial reproductive technologies – and improving access to such services for all – will be the start of a positive, global step-change not only for animals, but also for their owners, breeders, keepers, and guardians.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Insemigen?
Insemigen has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Insemigen last raise funding?
The most recent investment in Insemigen recorded on gritt.io was in February 2024.
When was Insemigen founded?
Insemigen was founded in 2022.
What industry is Insemigen in?
Insemigen operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Insemigen based?
Insemigen is headquartered in London, United Kingdom.